Search Results for "Neupro"

23:21 EDT 27th August 2014 | BioPortfolio

Original Source: Neupro reduces PLMS and total NSBP elevations in patients with RLS, study finds

UCB today announced data from a double-blind, placebo-controlled study that found that Neupro (Rotigotine Transdermal System) reduced total nocturnal systolic blood pressure elevations associated with periodic limb movements during sleep and total PL...

Matching Channels

None

Matching News

Neupro (Parkinson’s Disease) - Forecast and Market Analysis to 2022

Recently added to the BioPortfolio report store, Neupro (Parkinson’s Disease) - Forecast and Market Analysis to 2022 is a new report from GlobalData published on 2014-03-30. This 62-page report is...

Actavis Confirms Patent Challenge For Generic Neupro

WASHINGTON (dpa-AFX) - Actavis plc (ACT) confirmed Friday that it has filed an Abbreviated New Drug Application with the U.S. Food and Drug Administration seeking approval to market Rotigotine Ext...

Actavis files ANDA for generic version of Neupro

Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Rotigotine Extended-release Transde...

Actavis Confirms Generic Neupro® Patent Challenge

DUBLIN, Aug. 22, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking...

Restless Legs Syndrome - Pipeline Review, H1 2014

Recently added to the BioPortfolio report store, Restless Legs Syndrome - Pipeline Review, H1 2014 is a new report from Global Markets Direct published on 2014-05-14. This 56-page report is available...

PharmaPoint: Parkinson’s Disease - US Drug Forecast and Market Analysis to 2022

Recently added to the BioPortfolio report store, PharmaPoint: Parkinson’s Disease - US Drug Forecast and Market Analysis to 2022 is a new report from GlobalData published on 2014-03-30. This 209-pa...

PharmaPoint: Parkinson’s Disease - Brazil Drug Forecast and Market Analysis to 2022

Recently added to the BioPortfolio report store, PharmaPoint: Parkinson’s Disease - Brazil Drug Forecast and Market Analysis to 2022 is a new report from GlobalData published on 2014-03-30. This 16...

PharmaPoint: Parkinson’s Disease - Japan Drug Forecast and Market Analysis to 2022

Recently added to the BioPortfolio report store, PharmaPoint: Parkinson’s Disease - Japan Drug Forecast and Market Analysis to 2022 is a new report from GlobalData published on 2014-03-30. This 170...

Matching PubMed Articles

None

Search Whole site using Google

Loading
Search BioPortfolio:
Advertisement
Advertisement
Advertisement Advertisement